Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open Angle Glaucoma or Ocular Hypertension”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Testing effectiveness (Phase 2)Study completedNCT01915940
What this trial is testing

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT03310580
What this trial is testing

Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT02059278
What this trial is testing

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Nephron Pharmaceuticals Corporation 335
Not applicableStudy completedNCT01632423
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 10,337
Testing effectiveness (Phase 2)Study completedNCT01528111
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Lexicon Pharmaceuticals 63
Testing effectiveness (Phase 2)Study completedNCT00868894
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 49
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Large-scale testing (Phase 3)Study completedNCT01342094
What this trial is testing

DE-111 Against Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 166
Large-scale testing (Phase 3)Study completedNCT03235232
What this trial is testing

BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

Who this might be right for
Ocular HypertensionPrimary Open-angle Glaucoma
EMS 406
Not applicableStudy completedNCT01489670
What this trial is testing

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 387
Not applicableLooking for participantsNCT07076303
What this trial is testing

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

Who this might be right for
Primary Open Angle GlaucomaGlaucomaPrimary Open Angle Glaucoma or Ocular Hypertension
Brian Shafer 60
Large-scale testing (Phase 3)UnknownNCT04863365
What this trial is testing

Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
pH Pharma 110
Testing effectiveness (Phase 2)Study completedNCT04405245
What this trial is testing

Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
EyePoint Pharmaceuticals, Inc. 194
Not applicableStudy completedNCT05181046
What this trial is testing

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

Who this might be right for
GlaucomaGlaucoma, Open-AngleGlaucoma, Primary Open Angle+2 more
Nanodropper, Inc. 420
Post-approval studies (Phase 4)Study completedNCT00527592
What this trial is testing

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 54
Not applicableUnknownNCT04891588
What this trial is testing

Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Klinički Bolnički Centar Zagreb 50
Large-scale testing (Phase 3)Study completedNCT02565173
What this trial is testing

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma

Who this might be right for
Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Inotek Pharmaceuticals Corporation 303
Post-approval studies (Phase 4)Ended earlyNCT04702789
What this trial is testing

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Laboratorios Sophia S.A de C.V. 28
Large-scale testing (Phase 3)Ended earlyNCT02801617
What this trial is testing

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 116
Testing effectiveness (Phase 2)Study completedNCT02179008
What this trial is testing

Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Santen Inc. 184
Load More Results